These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 18845330)

  • 21. A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions.
    Kennedy LD; Case LD; Hurd DD; Cruz JM; Pomper GJ
    Transfusion; 2008 Nov; 48(11):2285-91. PubMed ID: 18673350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial.
    Reimers A; Hari Y; Müller U
    Allergy; 2000 May; 55(5):484-8. PubMed ID: 10843430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective safety analysis of an ultrarush specific immunotherapy in adults with wasp venom allergy.
    Lee H; Roediger C; Bauer A; Zuberbier T; Worm M
    Allergy; 2006 Oct; 61(10):1237-8. PubMed ID: 16942578
    [No Abstract]   [Full Text] [Related]  

  • 24. Answer to the letter of Brockow et al. concerning our article 'safety of rush insect venom immunotherapy. Results of a retrospective study in 178 patients'.
    Wenzel J; Meissner-Kraemer M; Bauer R; Bieber T; Gerdsen R
    Allergy; 2005 Jan; 60(1):127. PubMed ID: 15575945
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of beta-blockers during immunotherapy for Hymenoptera venom allergy.
    Müller UR; Haeberli G
    J Allergy Clin Immunol; 2005 Mar; 115(3):606-10. PubMed ID: 15753911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex.
    Nahm DH; Lee ES; Park HJ; Kim HA; Choi GS; Jeon SY
    Int Arch Allergy Immunol; 2008; 146(3):235-40. PubMed ID: 18268392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years.
    Dahl R; Kapp A; Colombo G; de Monchy JG; Rak S; Emminger W; Riis B; Grønager PM; Durham SR
    J Allergy Clin Immunol; 2008 Feb; 121(2):512-518.e2. PubMed ID: 18155284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber.
    Horak F; Zieglmayer P; Zieglmayer R; Lemell P; Devillier P; Montagut A; Mélac M; Galvain S; Jean-Alphonse S; Van Overtvelt L; Moingeon P; Le Gall M
    J Allergy Clin Immunol; 2009 Sep; 124(3):471-7, 477.e1. PubMed ID: 19647862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cetirizine reduces the number of tryptase-positive mast cells in psoriatic patients: a double-blind controlled study.
    Pestelli E; Caproni M; Giomi B; Volpi W; Spallanzani A; Cardinali C; Floriani I; Fabbri P
    Int J Tissue React; 2001; 23(3):97-103. PubMed ID: 11517856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allergen-specific immunotherapy alters the expression of B and T lymphocyte attenuator, a co-inhibitory molecule, in allergic rhinitis.
    Okano M; Otsuki N; Azuma M; Fujiwara T; Kariya S; Sugata Y; Higaki T; Kino K; Tanimoto Y; Okubo K; Nishizaki K
    Clin Exp Allergy; 2008 Dec; 38(12):1891-900. PubMed ID: 19016801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
    Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative antihistamine and anti-allergic effects of various antihistamine preparations].
    Fridliand DG; Gushchin IS; Poroshina IuA; Shul'zhenko AE
    Ter Arkh; 2002; 74(3):67-72. PubMed ID: 11980129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract.
    Fernández-Rivas M; Garrido Fernández S; Nadal JA; Díaz de Durana MD; García BE; González-Mancebo E; Martín S; Barber D; Rico P; Tabar AI
    Allergy; 2009 Jun; 64(6):876-83. PubMed ID: 19183164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory markers of mast cell and basophil activation in monitoring rush immunotherapy in bee venom-allergic children.
    Cichocka-Jarosz E; Dorynska A; Pietrzyk JJ; Spiewak R
    Immunotherapy; 2011 Aug; 3(8):1013-7. PubMed ID: 21843104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insect-sting allergy in Israel: immunotherapy with pure venoms.
    Bar-Sela S; Levo Y
    Isr J Med Sci; 1982 Apr; 18(4):487-90. PubMed ID: 7085249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial.
    Brockow K; Kiehn M; Riethmüller C; Vieluf D; Berger J; Ring J
    J Allergy Clin Immunol; 1997 Oct; 100(4):458-63. PubMed ID: 9338537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral peanut immunotherapy in children with peanut anaphylaxis.
    Blumchen K; Ulbricht H; Staden U; Dobberstein K; Beschorner J; de Oliveira LC; Shreffler WG; Sampson HA; Niggemann B; Wahn U; Beyer K
    J Allergy Clin Immunol; 2010 Jul; 126(1):83-91.e1. PubMed ID: 20542324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus.
    Tsai JJ; Liao EC; Tsai FH; Hsieh CC; Lee MF
    J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and characteristics of biphasic reactions after allergen immunotherapy.
    Scranton SE; Gonzalez EG; Waibel KH
    J Allergy Clin Immunol; 2009 Feb; 123(2):493-8. PubMed ID: 19064282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.